-
Mashup Score: 3Source: academic.oup.comCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 0Concept of Classical Herd Immunity May Not Apply to COVID-19 - 2 year(s) ago
David M Morens, Gregory K Folkers, Anthony S Fauci; The Concept of Classical Herd Immunity May Not Apply to COVID-19, The Journal of Infectious Diseases, , jiac
Source: OUP AcademicCategories: Infectious Disease, Latest HeadlinesTweet-
New in JID: A perspective on the concept of classical herd immunity and how it may not apply to COVID-19, from Dr. Anthony Fauci, and co-authors at @NIAIDNews. 📄:https://t.co/okdOyCNZtt #IDSAJournals #JInfectDis https://t.co/93pOxjRUqx
-
-
Mashup Score: 1Source: academic.oup.comCategories: Infectious Disease, Latest HeadlinesTweet
-
Help #JInfectDis improve understanding of the infectious disease risks associated with #homelessness by contributing to an upcoming supplement on homelessness and ID. Learn more: https://t.co/6Vimt1V9fk #IDSAJournals https://t.co/x8cGDHJ7LQ
-
-
Mashup Score: 1SARS-CoV-2 Effects at the Maternal-Fetal Interface - 2 year(s) ago
Roberta L DeBiasi, MD, MS; SARS-CoV-2 Effects at the Maternal-Fetal Interface, The Journal of Infectious Diseases, , jiac009, https://doi.org/10.1093/infdis/jia
Source: OUP AcademicCategories: Infectious Disease, Latest HeadlinesTweet-
A related commentary places the findings in context: 📄:https://t.co/dwWUCv3JLR #IDSAJournals #JInfectDis https://t.co/OOwU32WTxb
-
-
Mashup Score: 1Infectious Diseases Society of America Announces Next Editor-in-Chief of The Journal of Infectious Diseases - 2 year(s) ago
Cynthia L. Sears, MD, FIDSA The Infectious Diseases Society of America is pleased to announce that Cynthia L. Sears, MD, FIDSA, has been selected as the next editor-in-chief of The Journal of Infectious Diseases. Dr. Sears will succeed Martin S. Hirsch, MD, FIDSA, at the end of 2022, following his distinguished two decades of service to JID. “Throughout my…
Source: www.idsociety.orgCategories: Infectious Disease, Latest HeadlinesTweet-
Dr. Sears (@DrCindySears) will succeed Martin S. Hirsch, MD, FIDSA, following his distinguished two decades of service to JID. Learn more about Dr. Sears and the search process: https://t.co/q3UFS5b4NM #IDSAJournals #JInfectDis
-
-
Mashup Score: 12
Abstract. In a multi-state network, vaccine effectiveness (VE) against COVID-19 hospitalizations was evaluated among immunocompetent adults (≥18-years) during M
Source: OUP AcademicCategories: Infectious Disease, Latest HeadlinesTweet-
New in JID: mRNA vaccines reduced the risk of COVID-19 hospitalization by >95% in healthy adults without chronic medical conditions regardless of age, sex, obesity, or race/ethnicity. https://t.co/dwL1OaIfCt #JInfectDis #IDSAJournals https://t.co/AbVvlGkvrd
-
-
Mashup Score: 7Comparative immunogenicity and effectiveness of mRNA-1273, BNT162b2 and Ad26.COV2.S COVID-19 vaccines - 2 year(s) ago
AbstractBackground. Understanding immunogenicity and effectiveness of SARS-CoV-2 vaccines is critical to guide rational use.Methods. We compared the immunogenic
Source: OUP AcademicCategories: Infectious Disease, Latest HeadlinesTweet-
A new study in JID compared the immunogenicity and effectiveness of the three COVID-19 vaccines available in the U.S: https://t.co/0axLI2JZl7 #JInfectDis @vivek_naranbhai @MGHPathology @BalazsLab https://t.co/K9XCcWgPMj
-
-
Mashup Score: 2In Memoriam: George Gee Jackson - 2 year(s) ago
Richard M Novak, MD; In Memoriam: George Gee Jackson, The Journal of Infectious Diseases, , jiab544, https://doi.org/10.1093/infdis/jiab544
Source: OUP AcademicCategories: Infectious Disease, Latest HeadlinesTweet-
In JID, a remembrance of George Gee Jackson, MD, FIDSA, an accomplished researcher, nuanced clinician, mentor, past IDSA president and former JID editor in chief, who died in 2020 shortly after his 100th birthday: https://t.co/2aTxW1pa9d #IDSAJournals #JInfectDis https://t.co/27hyQTDXTG
-
-
Mashup Score: 4Effectiveness of a third dose of BNT162b2 mRNA vaccine - 3 year(s) ago
Abstract. A retrospective cohort study was carried out in a large Israeli health maintenance organization to determine vaccine effectiveness (VE) of a third dos
Source: OUP AcademicCategories: Infectious Disease, Latest HeadlinesTweet-
New in JID: A 3rd dose of the BNT162b2 vaccine 6 months after initial vaccination with 2 doses bolstered protection against SARS-CoV-2 infection, with a vaccine effectiveness of 89%, according to a retrospective cohort study. 📄 https://t.co/20PJRogaFY #JInfectDis #IDSAJournals https://t.co/sWdI0BBVp9
-
-
Mashup Score: 5Herpes Zoster Vaccines - 3 year(s) ago
Abstract. Herpes zoster (HZ) affects approximately 1 in 3 persons in their lifetime, and the risk of HZ increases with increasing age. The most common, debilita
Source: OUP AcademicCategories: Infectious Disease, Latest HeadlinesTweet-
Herpes zoster, or #shingles, affects approximately 1 in 3 people in their lifetime. A new JID supplement article provides an overview of the disease and 2 licensed vaccines for older adults that can prevent it. https://t.co/QgM6EQY1q9 #IDSAJournals #JInfectDis @gatesfoundation https://t.co/8RjL3pPmvc
-
JID: The empirical findings of this article suggest around 200 million people currently or previously experienced long-term health-related consequences of COVID-19. 📄:https://t.co/79Rd6odTJ5 #IDSAJournals #JInfectDis https://t.co/fQvPkUc6fM